Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. Juli 2015 08:00 ET | Quelle: Ziarco Group Ltd.

Ziarco Appoints Mike Grey as Executive Chairman of Board of Directors

CANTERBURY, United Kingdom, July 20, 2015 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a biopharmaceutical company focusing on inflammatory skin diseases, today announced the appointment of Mike Grey as...
10. Juni 2015 08:00 ET | Quelle: Ziarco Group Ltd.

Ziarco Initiates Phase 2a Clinical Trial of ZPL-389 in Atopic Dermatitis

CANTERBURY, England, June 10, 2015 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a biopharmaceutical company focusing on inflammatory skin diseases, today announced that it has dosed the first patient in its...
08. Juni 2015 08:00 ET | Quelle: Ziarco Group Ltd.

Ziarco Announces Appointment of Dr. Pablo Jimenez as Chief Medical Officer

CANTERBURY, UK, June 8, 2015 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a clinical-stage biopharmaceutical company focusing on inflammatory skin diseases, today announced the appointment of Pablo Jimenez,...
01. Dezember 2014 08:00 ET | Quelle: Ziarco Group Ltd.

Ziarco Announces Appointment of Mike Grey to Board of Directors

CANTERBURY, UK, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a biopharmaceutical company focusing on inflammatory skin diseases, today announced the addition of Mike Grey to its Board of...
10. November 2014 07:00 ET | Quelle: Ziarco Group Ltd.

Ziarco Raises $33.1 Million in Series B Financing

CANTERBURY, England, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Ziarco Group Ltd, a biopharmaceutical company focusing on inflammatory skin diseases, today announced the completion of a $33.1 million Series B...